跳至主要内容
临床试验/NCT03878615
NCT03878615已完成不适用

Inflammation and Organ Impact During Hepatic Surgery

Sahlgrenska University Hospital1 个研究点 分布在 1 个国家目标入组 18 人开始时间: 2018年11月10日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
18
试验地点
1
主要终点
Ischemic Intestinal Damage

研究概览

简要总结

Monitoring of inflammatory substances (such as interleukins, CRP, albumine), and markers of organ dysfunction (such as creatinine, proenkephaline, amylase, troponine, IFABP and lactate) during elective liver resection. The study also includes monitoring of hemodynamic parameters, blood loss and postoperative complications. Results are to be used för power calculation for future trials.

详细描述

During hepatic surgery, blood and urine samples will be obtained at 3 times during surgery, at 3 h after resection of liver, at 24 h after resection of liver and at post operative day 2, and subsequntly analyzed for the above mentioned substances. Routine labs will be monitored until patient is discharged from hospital. During surgery, hemodynamic parameters will be monitored by Picco calculations. Urine output and blood loss will be registred.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • ASA I-III Patient has given informed consent to participate in study.

排除标准

  • preoperative kidney failure (E-GFR >30), current infection treatment with corticosteroids coagulopathy surgical or anatomical conditions that makes patient unsuitable for participation (for example reoperation, need of vascular bypass, single tumor)

结局指标

主要结局

Ischemic Intestinal Damage

时间窗: from day of surgery until 24-48 hours postoperatively

rise in IFABP in nanograms/ml,

Kidney injury

时间窗: from day of surgery until 24-48 hours postoperatively

NAG units/g increase in urine.

Intestinal Bacterial Transloction

时间窗: from day of surgery until 24-48 hours postoperatively

Rise in D-lactate in micromol/ml

次要结局

  • Description of Inflammatory Response(from day of surgery and approximately 1 week onwards)

研究者

发起方
Sahlgrenska University Hospital
申办方类型
Other
责任方
Principal Investigator
主要研究者

Ellinor Wisén

MD, consultant

Sahlgrenska University Hospital

研究点 (1)

Loading locations...

相似试验